Login

Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

May 5, 2022
BioUtah News
Genovac Acquires Platform for Antibody Screening and Characterization Services

Genovac announces that the company has acquired Carterra’s LSA platform for use in its discovery services. Genovac, previously a part of Aldevron before a management buyout in 2020, has been providing discovery services to life science researchers since 1999 from its site in Freiburg, Germany. More recently, Genovac added production, characterization, and cell line development […]

May 5, 2022
BioUtah News
CoNextions TR Tendon Repair System receives FDA clearance

Expected to launch in May 2022, the novel system addresses traumatic tendon lacerations in the hand, wrist, and forearm CoNextions Inc., an innovator in tendon repair, is pleased to announce that CoNextions TR Tendon Repair System has received FDA 510(k) Clearance. Expected to launch in May 2022, the novel system addresses traumatic tendon lacerations in […]

May 5, 2022
BioUtah News
Blackrock Neurotech and Phantom Neuro Partner to Enable Prosthetics and Exoskeletons that Mimic Human Movement in Real-Time

The Phantom X system uses muscle-sensing implant technology to enable greater mobility in people with orthopedic injuries. SALT LAKE CITY and AUSTIN, Texas, April 26, 2022 /PRNewswire/ — Blackrock Neurotech, an  industry leader in brain-computer interface (BCI) technology, and Phantom Neuro, a recently launched neurotech startup that delivers a high accuracy system for lifelike control of robotic […]

May 5, 2022
BioUtah News
Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022

Highlights: Revenue of $164.9 million for the quarter ended March 31, 2022 Excluding revenue from divested businesses, revenue increased 11% year-over-year Diluted GAAP earnings per share (EPS) of $(0.26) and adjusted EPS of $(0.03) in the first quarter of 2022 improved by $0.26 and $0.03 year-over-year, respectively Ended the quarter with $339.2 million in cash, […]

May 5, 2022
BioUtah News
BD REPORTS SECOND QUARTER FISCAL 2022 FINANCIAL RESULT

FRANKLIN LAKES, N.J., May 5, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its second quarter of fiscal year 2022, which ended March 31, 2022. Revenue of $5.0 billion increased 2.1% as reported and 3.9% on currency-neutral basis Revenue driven by base revenue growth of […]

May 5, 2022
BioUtah News
BD Announces Inaugural Members of Scientific Advisory Board

Scientific Advisory Board Will Review Company Innovation Pipeline and Advise on Emerging Trends in Health Care, Science and Technology FRANKLIN LAKES, N.J., May 2, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the inaugural members of the BD Scientific Advisory Board (SAB), which is comprised […]

May 5, 2022
BioUtah News
Cibus Biotechnologies Celebrates a New Home, New Name

The innovation blooming in Utah’s BioHive was on full display Wednesday at a ribbon-cutting ceremony announcing a new home and new name for Cibus Biotechnologies. Under the new name, Seek Labs, the company has moved to a new location at Salt Lake City’s Northgate. The new location offers expanded laboratory facilities and room to grow. […]

May 4, 2022
BioUtah News
BioMérieux Joint Infection Panel Gets FDA De Novo Authorization

BioMérieux said on Wednesday that its BioFire Joint Infection (JI) Panel has received de novo authorization from the US Food and Drug Administration. 

May 4, 2022
BioUtah News
PolarityTE Announces First Subject Enrolled in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers

SALT LAKE CITY, May 3, 2022 /PRNewswire/ — PolarityTE, Inc. (Nasdaq: PTE) today announced the enrollment of the first subject in the Phase III pivotal study evaluating SkinTE in the investigational use of treatment of Wagner grade 2 diabetic foot ulcers (DFUs), entitled “Closure Obtained with Vascularized Epithelial Regeneration for DFUs with SkinTE,” or “COVER […]

May 4, 2022
BioUtah News
CenExel Acquires iResearch

Premier CNS-Focused Research Facilities in Georgia Join the CenExel Centers of Excellence Clinical Research Site Network

April 28, 2022
BioUtah News
BioUtah Remembers Senator Orrin Hatch

Senator Orrin Hatch, who served 42 years in the Senate and is the longest serving Senator in Utah’s history, died at 88 last Saturday. He is remembered fondly by Utah’s life sciences industry as a stalwart champion for medical innovation and improving the lives of patients. Reflecting on the Senator’s life and legacy, Kelvyn Cullimore, […]

April 28, 2022
BioUtah News
IDbyDNA Improves Analytical Performance and User Experience of Its Explify Platform and Respiratory and Urinary Pathogen ID/AMR Panels

IDbyDNA develops Precision Metagenomic solutions with faster, comprehensive pathogen identification, quantification, and profiling powered by AI-driven genomic analysis and next-generation sequencing.

April 20, 2022
BioUtah News
Biotech Perfect Day opens Location in BioHive Hub

The Gateway, a growing campus for life sciences companies, will expand and diversify the footprint of Perfect Day’s technology capabilities and teams

April 20, 2022
BioUtah News
Thermo Fisher Scientific Expands in Utah with New Bioprocessing Manufacturing Site in Ogden

Company now employs more than 2,000 people state-wide across three locations

April 19, 2022
BioUtah News
Merit Medical Receives FDA Clearance for SCOUT Bx™ Delivery System

New technology is designed to allow physicians to place SCOUT® reflector at time of biopsy for breast localization under stereotactic and MRI guidance

April 19, 2022
BioUtah News
Merit Medical Receives FDA “Breakthrough Device Designation” for Embosphere® Microspheres for Use in Genicular Artery Embolization for Symptomatic Knee Osteoarthritis

SOUTH JORDAN, Utah, March 07, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), announced today that it has received “breakthrough device designation” from the U.S. Food & Drug Administration (FDA) for Embosphere® Microspheres for the Genicular Artery Embolization (GAE) indication. GAE is a procedure intended to reduce pain and disability caused by knee osteoarthritis by […]

April 19, 2022
BioUtah News
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis C Viral Load Test

Co-Diagnostics announced that CoSara Diagnostics has received clearance by the CDSCO in India to manufacture and sell its SARAQ™ Hepatitis C Viral Load Kit as an in vitro diagnostic.

April 14, 2022
BioUtah News
2022 Medical Design Excellence Awards Winners: Radiological, Imaging, and Electromechanical Devices

Turner Imaging’s SmartC was recently recognized as a 2022 Medical Design Excellence Award Winner by the Medical Device and Diagnostics Industry QMed.

April 14, 2022
BioUtah News
Forbes Recognizes Recursion as a Best Startup Employer

Congratulations to the Recursion team and CEO Chris Gibson on making the Forbes’ list of America’s Best Startup Employers for 2022.

April 14, 2022
BioUtah News
April 14, 2022
BioUtah News
Inherent Biosciences awarded NIH SBIR Phase I Grant to commercialize innovative diagnosis of non-obstructive azoospermia (the most severe form of sperm dysfunction)

Inherent Biosciences announced an award from the National Institute of Child Health and Human Development’s Fertility and Infertility Branch to develop a clinical assay for improved diagnosis of non-obstructive azoospermia (NOA).

April 14, 2022
BioUtah News
Recursion is Granted Fast Track Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis

Recursion is Granted Fast Track Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis

April 13, 2022
BioUtah News
FDA Clears Four New Coronary Micro Support Catheters

Non-tapered metal-alloy support catheter platform receives FDA clearance for use in coronary and peripheral vasculature.

April 13, 2022
BioUtah News
JUSTICE CHRISTINE DURHAM JOINS WILSON SONSINI’S LITIGATION DEPARTMENT IN SALT LAKE CITY

Justice Durham’s Addition as Senior Of Counsel Bolsters the Firm’s Appellate Practice as Wilson Sonsini Continues to Grow in Salt Lake City